Wuhan Thalys Med Tech Co Ltd (603716) — Working Capital to Net Assets Ratio
Wuhan Thalys Med Tech Co Ltd (603716) has a Working Capital to Net Assets ratio of 44.7% as of March 2026. Working capital of CN¥441.28 Million (current assets of CN¥1.17 Billion minus current liabilities of CN¥725.25 Million) is measured against net assets of CN¥986.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Wuhan Thalys Med Tech Co Ltd (603716) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Wuhan Thalys Med Tech Co Ltd Working Capital to Net Assets (2011–2025)
This chart shows how Wuhan Thalys Med Tech Co Ltd's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 44.7%, reflecting working capital of CN¥441.28 Million against net assets of CN¥986.39 Million CNY. See how many days can Wuhan Thalys Med Tech Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Wuhan Thalys Med Tech Co Ltd (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Wuhan Thalys Med Tech Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 603716 company net worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 40.4% | CN¥365.60 Million | CN¥904.49 Million | CN¥1.24 Billion | CN¥872.77 Million | ▼ -34.0 pp |
| 2024 | 74.4% | CN¥715.68 Million | CN¥962.04 Million | CN¥2.09 Billion | CN¥1.37 Billion | ▼ -1.6 pp |
| 2023 | 76.0% | CN¥999.26 Million | CN¥1.31 Billion | CN¥2.39 Billion | CN¥1.40 Billion | ▲ +1.6 pp |
| 2022 | 74.4% | CN¥1.11 Billion | CN¥1.50 Billion | CN¥2.95 Billion | CN¥1.84 Billion | ▼ -12.0 pp |
| 2021 | 86.4% | CN¥1.51 Billion | CN¥1.74 Billion | CN¥3.24 Billion | CN¥1.74 Billion | ▲ +0.9 pp |
| 2020 | 85.4% | CN¥1.54 Billion | CN¥1.80 Billion | CN¥2.93 Billion | CN¥1.39 Billion | ▲ +29.4 pp |
| 2019 | 56.1% | CN¥909.01 Million | CN¥1.62 Billion | CN¥2.23 Billion | CN¥1.32 Billion | ▼ -6.5 pp |
| 2018 | 62.5% | CN¥1.02 Billion | CN¥1.63 Billion | CN¥1.95 Billion | CN¥934.32 Million | ▲ +5.1 pp |
| 2017 | 57.5% | CN¥576.92 Million | CN¥1.00 Billion | CN¥1.11 Billion | CN¥532.40 Million | ▼ -22.0 pp |
| 2016 | 79.5% | CN¥682.93 Million | CN¥859.29 Million | CN¥889.79 Million | CN¥206.86 Million | ▲ +10.6 pp |
| 2015 | 68.8% | CN¥323.69 Million | CN¥470.30 Million | CN¥505.72 Million | CN¥182.03 Million | ▼ -4.6 pp |
| 2014 | 73.4% | CN¥298.15 Million | CN¥405.99 Million | CN¥406.18 Million | CN¥108.03 Million | ▼ -1.7 pp |
| 2013 | 75.1% | CN¥259.99 Million | CN¥345.97 Million | CN¥330.30 Million | CN¥70.32 Million | ▼ -2.6 pp |
| 2012 | 77.7% | CN¥230.46 Million | CN¥296.50 Million | CN¥296.72 Million | CN¥66.25 Million | ▲ +0.2 pp |
| 2011 | 77.5% | CN¥196.75 Million | CN¥253.90 Million | CN¥250.04 Million | CN¥53.29 Million | — |